Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Roblox launches IP licensing platform

Digest more
Stocktwits on MSN · 1h
Roblox Announces IP Licensing Tool, Strikes Deals To Bring Experiences From Popular Netflix Shows Into Gameplay
Roblox (RBLX) unveiled a new feature on Tuesday that allows studios and creators to license their characters and other creative assets for use within the Roblox gaming platform. The company announced initial partnerships with Netflix (NFLX),

Continue reading

 · 12h · on MSN
Roblox launches IP licensing platform, partners with Netflix, Lionsgate
C21Media · 1h
Netflix, Lionsgate and Sega offer key properties as Roblox expands IP licensing scheme
12hon MSN
Roblox creators can now make their own Stranger Things and Twilight games
Roblox is launching a new licensing platform that will make it easier for companies to offer their intellectual property (IP) ...
13hon MSN
Roblox Launches New Licensing Platform With Lionsgate, Netflix, Sega and Kodansha as Founding Partners (EXCLUSIVE)
Roblox is launching a new licensing platform to streamline the process for IP rights holders to partner with creators on the ...
14h
What's Going On With Roblox Stock On Tuesday?
Roblox shares edge higher as it launches a licensing platform to simplify IP access for creators and attract major media ...
Gameranx
13h
Stranger Things, Squid Game, Twilight & More Officially Coming To Roblox
Roblox is going to have more IPs adapted into its video game. Lionsgate, Netflix, Sega, and Kodansha join a new licensing program.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy